The AMLprofiler in vitro diagnostic test simplifies the challenging task to recognize Acute Myeloid Leukemia (AML) subtypes and make individualized therapy decisions. The test determines relevant diagnostic and prognostic markers for AML in one single microarray-based assay. As compared to existing diagnostic methods, the AMLprofiler delivers faster results and significantly improved patient classification on a fully integrated and robust array platform.

Dr. Molewaterplein 50, Suite Ee-1540, 3015 GE Rotterdam. The Netherlands, Europe. Phone: +31 (0)10 70 43 491. Fax: +31 (0)10 70 44 161. E-mail: